SCP
IDXX icon

Sivia Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Sivia Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-567
Closed -$384K – 542
2025
Q4 		$384K Sell
567
-3
-0.5% -$2.04K 0.08% 335
2025
Q3 		$364K Buy
570
+76
+15% +$46.1K 0.1% 257
2025
Q2 		$265K Buy
+494
New +$236K 0.09% 321

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sivia Capital Partners's IDXX Position: Q1 2026 in Review

Sivia Capital Partners sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 567 shares — an estimated $384K sold.

Sivia Capital Partners first reported a position in IDXX in Q2 2025 and held it in 3 quarters. The position peaked at $384K in Q4 2025. 1,318 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Sivia Capital Partners reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Sivia Capital Partners sold 567 Idexx Laboratories shares in Q1 2026, an estimated $384K.
  • Sivia Capital Partners first reported a position in Idexx Laboratories in Q2 2025 and held it in 3 quarters.
  • Sivia Capital Partners's Idexx Laboratories position peaked at $384K in Q4 2025.
  • 1,318 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Sivia Capital Partners's 13F filing for Q1 2026, filed 13 May 2026.